Globus Medical Reports Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Globus Medical (GMED) PT Raised to $80 at BofA Securities
November 6, 2024 5:57 AM ESTBofA Securities analyst Craig Bijou raised the price target on Globus Medical (NYSE: GMED) to $80.00 (from $55.00) while maintaining a Underperform rating.
The analyst comments "GMED continues to deliver beat and raises showing that it has managed the NuVasive integration better than... More
Globus Medical (GMED) Tops Q3 EPS by 18c
November 5, 2024 4:24 PM ESTGlobus Medical (NYSE: GMED) reported Q3 EPS of $0.83, $0.18 better than the analyst estimate of $0.65. Revenue for the quarter came in at $625.7 million versus the consensus estimate of $604.71 million.
GUIDANCE:
Globus Medical sees FY2024 EPS of $2.90-$3.00, versus the consensus of... More
